We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
US-based SeaStar Medical has entered into an exclusive US license and distribution agreement for its Selective Cytopheretic Device (SCD) with Nuwellis for its use in the treatment of
GIE Medical said that it has initiated two clinical trials in the US to evaluate ProTractX3 TTS DCB, the company’s multi-stage drug-coated balloon (DCB) technology. According to the
QIAGEN has secured approval for its therascreen KRAS RGQ PCR kit (therascreen KRAS kit) from the US Food and Drug Administration (FDA) as a companion diagnostic (CDx) test
NeurOptics’ Neurological Pupil index (NPi) and automated pupillometry are now included in the updated 2021 European Resuscitation Council (ERC) and European Society of Intensive Care Medicine (ESICM) Guidelines
The Oregon State University (OSU) said that researchers from its College of Engineering have developed a sensor system that can potentially improve the lives of epilepsy patients. According
Peijia Medical, in partnership with inQB8 Medical Technologies, has completed the first-in-human implantation of the MonarQ Transcatheter Tricuspid Valve Replacement (TTVR) System. The device was implanted in a
Canon Inc. announced today that the company has decided to establish a new subsidiary, to be named Canon Healthcare USA, INC. By strengthening its presence in the highly
GE Healthcare today announced the launch of SIGNA Experience, a platform of four synergistic technologies that help users through the diagnostic journey. This integrated collection works together to
AMPEL BioSolutions, a US-based precision medicine company, has unveiled the new CardioGENE lab test to predict heart diseases and provide decision support for prophylactic therapies for women with
Sequana Medical’s fully implantable alfapump device for the treatment of recurrent or refractory ascites due to liver cirrhosis has met all primary effectiveness endpoints in the pivotal cohort